Description
The CORE™ Ultrafiltration Device is a precision-engineered, point-of-care concentrator that isolates and concentrates Alpha-2-Macroglobulin (A2M), fibrinogen, and other bioactive plasma proteins from small blood volumes. Utilizing 20 kDa polysulfone ultrafiltration technology from EmCyte Corporation, this system delivers superior protein recovery, maintaining ≥90% retention and up to 6x concentration — all while preserving the natural bioactivity of key plasma components.
Key Features:
- ≥6x Concentration Efficiency — Achieves high A2M concentration for enhanced tissue protection and regenerative potential
- Natural Blood Component — A2M is a naturally occurring plasma protein known for its ability to inhibit destructive enzymes and support tissue repair
- Advanced Ultrafiltration System — The EmCyte CORE™ system ensures fast, precise concentration of platelet-poor plasma proteins with minimal sample handling
- Point-of-Care Ready — Designed for in-office use, enabling clinicians to deliver immediate, biologically active protein therapy
Compatible with all EmCyte PRP systems.
